BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32314335)

  • 21. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's esophagus.
    Shalauta MD; Saad R
    Am Fam Physician; 2004 May; 69(9):2113-8. PubMed ID: 15152957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
    Peitz U; Malfertheiner P
    Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging endoscopic techniques for the identification of esophageal disease.
    Triadafilopoulos G; Akiyama J
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):605-13. PubMed ID: 26753504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment endoscopy--pro & contra: endoscopy is needed before treatment in all patients with gastroesophageal reflux disease.
    Pace F; Manes G; Conio M; Bianchi Porro G
    Endoscopy; 2006 Mar; 38(3):271-5. PubMed ID: 16528655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How far to go? Screening and surveillance in Barrett's esophagus.
    Lieberman DA; Sampliner RE
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S19-26. PubMed ID: 11225349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic accuracy of esophageal capsule endoscopy in patients with gastroesophageal reflux disease and Barrett's esophagus: a blinded, prospective study.
    Sharma P; Wani S; Rastogi A; Bansal A; Higbee A; Mathur S; Esquivel R; Camargo L; Sampliner RE
    Am J Gastroenterol; 2008 Mar; 103(3):525-32. PubMed ID: 17459025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Course of erosive gastroesophageal reflux disease (ERD)--a prospective examination under therapeutic daily life conditions with a mean follow-up of 6.5 years.
    Hartmann D; Kudis V; Jakobs R; Riemann JF; Schilling D
    Z Gastroenterol; 2006 Oct; 44(10):1039-42. PubMed ID: 17063432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroesophageal reflux disease and Barrett's esophagus.
    Katzka DA; Rustgi AK
    Med Clin North Am; 2000 Sep; 84(5):1137-61. PubMed ID: 11026922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers for non-endoscopic examination of esophageal mucosa.
    Deissová T; Kala Z; Slabý O; Dolina J; Kroupa R; Kunovský L; Hollá LI; Linhartová PB
    Vnitr Lek; 2020; 66(7):13-19. PubMed ID: 33380129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal capsule endoscopy for Barrett's esophagus screening: a hard pill to swallow?
    Hur C
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):307-9. PubMed ID: 17257904
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
    Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
    Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.
    Morganstern B; Anandasabapathy S
    Geriatrics; 2009 Jul; 64(7):9-12. PubMed ID: 19586085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux.
    Csendes A; Smok G; Burdiles P; Quesada F; Huertas C; Rojas J; Korn O
    Dis Esophagus; 2000; 13(1):5-11. PubMed ID: 11005324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common questions about Barrett esophagus.
    Zimmerman TG
    Am Fam Physician; 2014 Jan; 89(2):92-8. PubMed ID: 24444576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus.
    DeVault K; McMahon BP; Celebi A; Costamagna G; Marchese M; Clarke JO; Hejazi RA; McCallum RW; Savarino V; Zentilin P; Savarino E; Thomson M; Souza RF; Donohoe CL; O'Farrell NJ; Reynolds JV
    Ann N Y Acad Sci; 2013 Oct; 1300():278-295. PubMed ID: 24117649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroesophageal reflux and cancer.
    Turcotte S; Duranceau A
    Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Screening Tests for Barrett's Esophagus.
    Codipilly DC; Iyer PG
    Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.